SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-023039
Filing Date
2023-05-18
Accepted
2023-05-18 16:16:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A crsp-defa_14a-2023_emplo.htm DEFA14A 37196
  Complete submission text file 0000950170-23-023039.txt   38141
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37923 | Film No.: 23936287
SIC: 2836 Biological Products, (No Diagnostic Substances)